News | February 29, 2024
Bajaj Healthcare enters into definitive CDMO Agreement for 15 APIs with UK/EU customers
BHL will undertake the development and supply of these molecules
BHL will undertake the development and supply of these molecules
The plant will drive pharmaceutical innovation in the Northeastern India
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
The board gave in-principle approval for expansion of company's footprint in Lucknow
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Subscribe To Our Newsletter & Stay Updated
